Also from this source

You just read:

GSK Presents New Data at ACR for BENLYSTA (belimumab) for Subcutaneous Use (SC), Showing Reduced Need to Increase Corticosteroid Dose

News provided by

GSK

Nov 07, 2017, 11:00 ET